Evidence map›Paper›PMID 30704404›Full record

ArticleBMC bioinformatics2019

InTAD: chromosome conformation guided analysis of enhancer target genes.

Konstantin Okonechnikov, Serap Erkek, Jan O Korbel, Stefan M Pfister, Lukas Chavez

Abstract read
In one paragraph

Article in BMC bioinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Konstantin OkonechnikovHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.
Serap ErkekHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.
Jan O KorbelGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Stefan M PfisterHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.
Lukas ChavezDepartment of Medicine, Division of Medical Genetics, University of California San Diego (UCSD), San Diego, USA. lukaschavez@ucsd.edu.

Funding

Deutsches Krebsforschungszentrum #Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ) #UC San Diego Moores Cancer Center #
6 · The paper itself

Abstract

backgroundHigh-throughput technologies for analyzing chromosome conformation at a genome scale have revealed that chromatin is organized in topologically associated domains (TADs). While TADs are relatively stable across cell types, intra-TAD activities are cell type specific. Epigenetic profiling of different tissues and cell-types has identified a large number of non-coding epigenetic regulatory elements ('enhancers') that can be located far away from coding genes. Linear proximity is a commonly chosen criterion for associating enhancers with their potential target genes. While enhancers frequently regulate the closest gene, unambiguous identification of enhancer regulated genes remains to be a challenge in the absence of sample matched chromosome conformation data.

resultsTo associate enhancers with their target genes, we have previously developed and applied a method that tests for significant correlations between enhancer and gene expressions across a cohort of samples. To limit the number of tests, we constrain this analysis to gene-enhancer pairs embedded in the same TAD, where information on TAD boundaries is borrowed from publicly available chromosome conformation capturing ('Hi-C') data. We have now implemented this method as an R Bioconductor package 'InTAD' and verified the software package by reanalyzing available enhancer and gene expression data derived from ependymoma brain tumors.

conclusionThe open-source package InTAD is an easy-to-use software tool for identifying proximal and distal enhancer target genes by leveraging information on correlated expression of enhancers and genes that are located in the same TAD. InTAD can be applied to any heterogeneous cohort of samples analyzed by a combination of gene expression and epigenetic profiling techniques and integrates either public or custom information of TAD boundaries.

Indexed as

SoftwareChromatinChromosomesComputational BiologyEnhancer Elements, GeneticEpigenesis, GeneticHumansMolecular ConformationChromatinEnhancersEpigenomicsTopologically associated domainsTranscriptomics

Identifiers

PMID30704404
PMCPMC6357397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.